About this trial
The aim of this study is to assess outcomes of MPFLR With Fascia Lata Allograft, Based on Isometry Assessment Combined With Elmslie-Trillat Tibial Tuberosity Osteotomy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Lateral patellar dislocation with subsequent instability
Failure of non-operative treatment
Disqualifiers
Active inflammation of the knee;
Previous surgeries on the patellofemoral joint;
Fractures around the knee
Trial design
Single group
Treatments tested in this trial
Medial Patellofemoral Ligament Reconstruction (MPFLR) With Fascia Lata Allograft, Based on Isometry Assessment Combined With Elmslie-Trillat Tibial Tuberosity Osteotomy.
Procedure/SurgeryMedial Patellofemoral Ligament Reconstruction (MPFLR) With Fascia Lata Allograft, Based on Isometry Assessment Combined With Elmslie-Trillat Tibial Tuberosity Osteotomy. Management of any accompanying patellofemoral lesions will be performed as well.
Treatment groups
Trial outcomes
Primary outcomes
Lateral patella stability - apprehension test
Apprehension test at 30 degrees of knee flexion
Lateral patella stability - lateral luxation test
Lateral luxation test at 30 degrees of knee flexion
Lateral patella stability - apprehension test
Apprehension test at 30 degrees of knee flexion
Lateral patella stability - lateral luxation test
Lateral luxation test at 30 degrees of knee flexion
Secondary outcomes
The functional assessment with the The International Knee Documentation Committee Questionnaire (IKDC)
Min of 0 max of 87 points, higher scores mean a better outcome
The functional assessment with the The International Knee Documentation Committee Questionnaire (IKDC)
Min of 0 max of 87 points, higher scores mean a better outcome
The functional assessment with the Knee injury and Osteoarthritis Outcome Score
Min of 0 max of 100 points, higher scores mean a better outcome
The functional assessment with the Knee injury and Osteoarthritis Outcome Score
Min of 0 max of 100 points, higher scores mean a better outcome
Sponsors and contacts
Click on the lead sponsor to view all of their trials.